In the near future, the cell therapy technologies industry is poised to undergo a transformative revolution, revolutionizing the landscape of modern medicine. Advancements in regenerative medicine, genetic engineering, and personalized therapies are driving unprecedented progress. Stem cell therapies, gene editing techniques like CRISPR-Cas9, and CAR-T cell immunotherapies are rapidly becoming mainstream treatments for a wide range of diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. The convergence of these cutting-edge technologies promises to unlock the full potential of cell-based therapies, enabling targeted and precise interventions tailored to individual patients' unique genetic makeup. As research continues to flourish and regulatory frameworks evolve, accessibility and affordability of these therapies are likely to improve, paving the way for a new era of healthcare, where cell-based treatments offer hope for previously incurable ailments, significantly improving patient outcomes and transforming the paradigm of medical care.
Cell Therapy Technologies Market in terms of revenue was estimated to be worth $4.2 Billion in 2023 and is poised to reach $7.8 Billion by 2028, growing at a CAGR of 13.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Major factors driving the market growth at significant CAGR are increasing the prevalence of chronic diseases, increasing the funding for research, and the launch of novel products in the market by key market players.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
Browse in-depth TOC on "Cell Therapy Technologies Market"
210 - Tables
49 - Figures
236 - Pages
Cell Therapy Technologies Market Scope:
Report Coverage | Details |
Market Revenue in 2023 | $4.2 Billion |
Estimated Value by 2028 | $7.8 Billion |
Growth Rate | Poised to grow at a CAGR of 13.3% |
Market Size Available for | 2021-2028 |
Forecast Period | 2023–2028 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Product, Cell Type, Process, End-user, and Region |
Geographies Covered | North America, Europe, Asia Pacific, Latin America and the Middle East & Africa |
Report Highlights | Updated financial information / product portfolio of players |
Key Market Opportunities | Increased focus on personalized medicine |
Key Market Drivers | Rising incidence of chronic and infectious diseases |
The cell processing segment accounted for the largest share of the process segment in the cell therapy technologies market in 2022.
Based on process, the global cell therapy technologies market is segmented into cell processing, cell preservation, distribution & handling, process monitoring & quality control. In 2022, the cell processing segment held dominant share in cell therapy technologies market. The factors attributable to the dominance are adoption of technologically advance products and instruments in the market.
The biopharmaceutical & biotechnology companies sub segment accounted for the largest share of the end user segment in the cell therapy technologies market in 2022.
Based on end users, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies, CROS & CMOs, research institutes & cell banks. In 2022, the biopharmaceutical & biotechnology companies segment accounted for the largest share of the cell therapy technologies market. The segment held the dominant share in the market owing to various factors such as increased funding, rising academia and biopharma collaboration for research and development in cell-therapy products.
North America dominated the cell therapy technologies market.
Based on region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The increasing funding for research for chronic diseases and the presence of top players operating in the region are key factors supporting the growth of the North America cell therapy technologies market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Increased adoption of cell-based therapy in emerging countries coupled with emphasis on geographical expansions by key market players in emerging countries these are some of the factors anticipated to contribute to the cell therapy technologies market growth in the Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978
Cell Therapy Technologies Market Dynamics:
Drivers:
- Rising incidence of chronic and infectious diseases
Restraints:
- High cost of cell-based research and low success rate
Opportunities:
- Increased focus on personalized medicine
Challenges:
- Survival of small players and new entrants
Key Market Players:
The cell therapy technologies market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland)Danaher Corporation (US), Sartorius AG (Germany) are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
While cell therapies hold tremendous promise, it's essential to address challenges such as manufacturing scalability, regulatory approvals, and ensuring equitable access to these advanced treatments. Nevertheless, the advantages offered by cell therapy technologies make them a compelling and transformative area of medicine with the potential to improve the lives of countless patients worldwide.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213334978
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-therapy-technologies-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-therapy-technologies.asp
